ScholarWorks@Korea University College of Medicine: Lee, Seung Heon

Detailed Information

Lee, Seung Heon (이승헌)

Ansan Hospital (Department of Pulmonary, Allergy, and Critical Care Medicine, Ansan Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Tuberculosis:8||tuberculosis:6||Latent tuberculosis:5||multidrugresistant tuberculosis:4||Reactive oxygen species:3||moxifloxacin:3||Interferongamma release assay:3||tuberculin skin test:3||Prognosis:2||COVID19 pandemic:2||South Korea:2||Lung neoplasms:2||Surgery:2||Tuberculin test:2||latent tuberculous infection:2||levofloxacin:2||Nonsmall cell lung cancer:2||Oxidative stress:2||Immigrants:2||Diagnosis:2||Biomarker:2||Mycobacterium tuberculosis:2||Digital tomosynthesis:1||Disease outbreaks:1||Drug therapy:1||ERCC1:1||End stage renal disease:1||FEV1:1||FK224:1||FVC:1||Factor XIII:1||Global longitudinal strain:1||Human plasma:1||Ikappa B kinase inhibitor:1||ICU admission:1||Immunoglobulin G:1||Infection:1||Infection Control:1||Inflammation:1||Interleukin18:1||Interstitial:1||Korea:1||Latent Tuberculosis:1||Linezolid:1||Lipoma:1||Liquid chromatography (LC)tandem mass spectrometry (MS/MS):1||Lung diseases:1||Lymph node:1||Lymph nodes:1||Mediastinum:1||Migration:1||Morocco:1||Mortality:1||Multidrug resistant tuberculosis:1||Multicenter randomized trial:1||Multidrugresistant:1||Multidrugresistant tuberculosis:1||Multiple pulmonary nodules:1||Multiple reaction monitoring:1||Neoplasm metastasis:1||Noninferiority:1||Platinum:1||Pleura:1||Pleural effusion:1||Pneumonia:1||Predictive marker:1||Procalcitonin:1||Programmed death ligand 1:1||Pulmonary adenocarcinoma:1||Pulmonary edema:1||Pulmonary sarcomatoid carcinoma:1||QuantiFERON (R) test:1||QuantiFERON test:1||Radiation dose:1||Receptor:1||Republic of Korea:1||Respiration, Artificial:1||Respiratory Distress Syndrome, Adult:1||Reversion:1||Rifampicin prophylaxis:1||Sarcoma, endometrial stromal:1||Sasang constitutional medicine:1||Sepsis:1||Serial testing:1||Serum:1||Shock:1||Shorter regimen:1||Single nucleotide polymorphism:1||Smoking:1||SoEum type:1||SoYang type:1||Strains:1||TB control:1||TB incidence:1||TB outbreaks:1||TBspecific mortality:1||TaeEum type:1||Therapeutics:1||Thoracolith:1||Thrombophlebitis:1||Thymidylate synthase:1||Transglutaminase 2:1||Transmission:1||Trauma:1||Treatment:1||Treatment outcome:1||Vascular endothelial growth factor:1||VentilatorInduced Lung Injury:1||Ventilatorassociated event:1||Ventilatorassociated pneumonia:1||Whole Genome Sequencing:1||artificial:1||chronic obstructive pulmonary disease:1||close contact:1||comorbidities:1||contact screening:1||costeffectiveness:1||critical care:1||critical illness:1||cycloserine:1||disabilityadjusted life years:1||drug monitoring:1||drug toxicity:1||drugsusceptible tuberculosis:1||economic disease burden:1||education level:1||epidermal growth factor:1||fluoroquinolone:1||fluoroquinolones:1||histological type:1||hospital mortality:1||hyperphosphatemia:1||hypophosphatemia:1||incidence:1||interferonγ assay:1||interleukin27:1||laboratory crosscontamination:1||length of stay in hospital:1||lost to followup rate:1||lung injury:1||mass screening:1||medical costs:1||medication adherence:1||medication event monitoring system:1||microbial sensitivity tests:1||multidrugresistant tuberculosis:1||multidrug resistance:1||neoplasm staging:1||neurogenic inflammation:1||nonsmallcell lung carcinoma:1||patient characteristics:1||phosphate:1||plasma extravasation:1||prediction model:1||prevalence:1||preventive intervention:1||prothionamide:1||respiration:1||respiratory distress syndrome:1||respiratory insufficiency:1||rifampicin:1||risk factors:1||severity of illness:1||single nucleotide polymorphism:1||socioeconomic status:1||strains:1||success rate:1||tobacco smoke:1||tuberculosis patient:1||vulnerable group:1||wholegenome sequencing:1||잠복결핵:1||진단:1||Acute Lung Injury:1||치료:1||Acute lung injury:1||Adolescent:1||Airway disease:1||Antituberculosis drugs:1||Antibiotic prophylaxis:1||Atypical mycobacteria:1||Bacterial:1||Bedaquiline:1||Biomarkers:1||COVID19:1||Cardiomyopathies:1||Cavity:1||Chemotherapy:1||Chest radiography:1||Cholecystitis:1||Chronic bronchitis:1||Chronic obstructive pulmonary disease:1||ChurgStrauss syndrome:1||Computed tomography:1||Delamanid:1||Dialysis:1||

STATISTICS: Total View :12,729,195; Today View :13,502

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE